The Role of Pan-Immune-Inflammation Value in Determining the Severity of Coronary Artery Disease in NSTEMI Patients
Journal of Clinical Medicine · 25.02.2024 · 13 (5) · 1295
DOI: 10.3390/jcm13051295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 25.02.2024. Verfasst von Zeki Cetinkaya und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ministry of Health, Elazıg Fethi Sekin City Hospital, Elazıg 23280, Turkey. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Even though medication and interventional therapy have improved the death rate for non-ST elevation myocardial infarction (NSTEMI) patients, these patients still have a substantial residual risk of cardiovascular events. Early identification of high-risk individuals is critical for improving prognosis, especially in this patient group. The focus of recent research has switched to finding new related indicators that can help distinguish high-risk patients. For this purpose, we examined the relationship between the pan-immune-inflammation value (PIV) and the severity of coronary artery disease (CAD) defined by the SYNTAX score (SxS) in NSTEMI patients.
Methods
Based on the SxS, CAD patients were split into three groups. To evaluate the risk variables of CAD, multivariate logistic analysis was employed.
Results
The PIV (odds ratio: 1.003; 95% CI: 1.001–1.005; p = 0.005) was found to be an independent predictor of a high SxS in the multivariate logistic regression analysis. Additionally, there was a positive association between the PIV and SxS (r: 0.68; p < 0.001). The PIV predicted the severe coronary lesion in the receiver-operating characteristic curve analysis with a sensitivity of 91% and specificity of 81.1%, using an appropriate cutoff value of 568.2.
Conclusions
In patients with non-STEMI, the PIV, a cheap and easily measured laboratory variable, was substantially correlated with a high SxS and the severity of CAD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Ministry of Health, Elazıg Fethi Sekin City Hospital, Elazıg 23280, Turkey.
- Department of Cardiology, Erciyes University Faculty of Medicine, Kayseri 38039, Turkey.
- Department of Cardiovascular Surgery, Erciyes University Faculty of Medicine, Kayseri 38039, Turkey.
- Department of Cardiology, University of Health Sciences, Kayseri Education and Research Hospital, Kayseri 38100, Turkey.
- Department of Cardiology, Fırat University Faculty of Medicine, Elazıg 23119, Turkey.
ORCID-Profile: Zeki Cetinkaya, Saban Kelesoglu, Yucel Yilmaz, Mehdi Karasu
Zitieren
APA
Cetinkaya, Z., Kelesoglu, S., Tuncay, A., Yilmaz, Y., Karaca, Y., Karasu, M., Secen, O., Cinar, A., Harman, M., Sahin, S., Akin, Y., & Yavcin, O. (2024). The Role of Pan-Immune-Inflammation Value in Determining the Severity of Coronary Artery Disease in NSTEMI Patients. Journal of Clinical Medicine, 13(5), 1295. https://doi.org/10.3390/jcm13051295
Vancouver
Cetinkaya Z, Kelesoglu S, Tuncay A, Yilmaz Y, Karaca Y, Karasu M, et al. The Role of Pan-Immune-Inflammation Value in Determining the Severity of Coronary Artery Disease in NSTEMI Patients. Journal of Clinical Medicine. 2024;13(5):1295. doi:10.3390/jcm13051295
BibTeX
@article{Cetinkaya2024,
author = {Cetinkaya, Zeki and Kelesoglu, Saban and Tuncay, Aydin and Yilmaz, Yucel and Karaca, Yucel and Karasu, Mehdi and Secen, Ozlem and Cinar, Ahmet and Harman, Murat and Sahin, Seyda and Akin, Yusuf and Yavcin, Ozkan},
title = {The Role of Pan-Immune-Inflammation Value in Determining the Severity of Coronary Artery Disease in NSTEMI Patients},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {5},
pages = {1295},
doi = {10.3390/jcm13051295}
}
EUVIMED